NMPA Accepts NDA for Localized Manufacturing of Multinational Client’s Biologic
Altruist Biologics says its integrated CMC platform supported NMPA acceptance of an NDA for localized manufacturing of a multinational client’s biologic.
Related stories
Nasdaq Falls as Tech Earnings Disappoint
U.S. markets declined, while futures fell further after the close as more technology results disappointed. Losses extended across AI and software stocks.
M impact | EQUITY | Oct 29, 2026, 11:41 PM UTC
Google Agrees to Pay $150 Million for PG&E Connection in San Jose
Google agreed to make an up-front payment of $150 million to cover the cost of a PG&E electric connection in San Jose.
L impact | EQUITY | Oct 29, 2026, 11:40 PM UTC
Cann Group reports Q1 revenue of A$3.45 million
Cann Group reported unaudited Q1 revenue of A$3.45 million.
M impact | EQUITY | Oct 29, 2026, 11:39 PM UTC
Amazon shares fall as AI spending outpaces cloud growth
Amazon’s fourth-quarter revenue outlook is reported against market expectations.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
Quaker Chemical Reports Quarterly Results
Quaker Chemical reported results for the quarter ended September 30; the supplied text provides no figures.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC
PennyMac Mortgage Investment Trust Reports Quarterly Results
PennyMac Mortgage Investment Trust reports results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:37 PM UTC